Immuneering recently announced positive initial Phase 2a data, including complete and partial responses, with IMM-1-104 in combination ... our Quarterly Report on Form 10-Q for the three month ...
After hours: October 18 at 5:35 PM EDT Loading Chart for FORM ...
Biotechnology company that is a leader in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune disease.
1294.65 as on 18 Oct, 2024, 03:54 PM IST. On previous day, the Kalpataru Power Share Price (NSE) closed at Rs. 1294.65, featuring among the most traded securities on the National Stock Exchange.